Prognostic Significance of AKT/mTOR Signaling in Advanced Neuroendocrine Tumors Treated With Somatostatin Analogs

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s36330
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Multiple Effects of Somatostatin Analogs Verified in Three Cases of Metastasized Neuroendocrine Tumors of the Gastroenteropancreatic System

Tumori
MedicineCancer ResearchOncology
2006English

Somatostatin Receptor Endoradiotherapy of Neuroendocrine Tumors: Experience in Hungarian Patients

Orvosi Hetilap
Medicine
2011English

Role of Somatostatin Analogues in the Treatment of Neuroendocrine Tumors

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2015English

Targeting the PI3K/AKT/mTOR Signaling Axis in Children With Hematologic Malignancies

Paediatric Drugs
Child HealthPediatricsPerinatologyPharmacology
2012English

Prevalence and Prognostic Significance of Neuroendocrine Cells in Esophageal Adenocarcinoma

Modern Pathology
Forensic MedicinePathology
2000English

Targeting the PI3-Kinase/Akt/mTOR Signaling Pathway

Surgical Oncology Clinics of North America
SurgeryOncology
2013English

Inhibition of Phosphatidylinositol 3-Kinase/Akt Signaling Suppresses Tumor Cell Proliferation and Neuroendocrine Marker Expression in GI Carcinoid Tumors

Annals of Surgical Oncology
OncologySurgery
2009English

The Place of Somatostatin Analogs in the Diagnosis and Treatment of the Neuoroendocrine Glands Tumors

2011English

Tumor Suppressor Role of Notch-1 Signaling in Neuroendocrine Tumors

Oncologist
Cancer ResearchMedicineOncology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy